A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, andPharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent GlioblastomaMultiforme (WHO Grade IV) After Failure of Standard First Line Th

Project: Research project

Project Details

Description

A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Th
StatusActive
Effective start/end date8/11/21 → 8/31/26

Funding

  • CNS PHARMACEUTICALS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint